Stock Quality:
Last 7 days
17.5%
Last 30 days
47.5%
Last 90 days
76.0%
Trailing 12 Months
79.5%
SVRA RSI Chart
Growth
Profitability
Size
Dilution Risk
Balance Sheet
Momentum
Funds Popularity
Insider Trading
Historical Charts for Stock Metrics
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2024 | 0 | 0 | 0 | 0 |
| 2020 | 22.3M | 14.9M | 7.6M | 257.0K |
| 2019 | 0 | 0 | 0 | 29.6M |
| 2018 | 15.0M | 22.3M | 0 | 0 |
| 2017 | 7.7M | 0 | 0 | 0 |
| 2016 | 140.5K | 227.0K | 313.5K | 400.0K |
| 2015 | 0 | 0 | 0 | 54.0K |
| 2010 | 0 | 0 | 0 | 489.0K |
| CEO | Mr. Matthew Pauls J.D., M.B.A. |
|---|---|
| WEBSITE | savarapharma.com |
| SECTOR | Healthcare |
| INDUSTRY | Biotechnology |
| EMPLOYEES | 28 |